142 related articles for article (PubMed ID: 23276469)
21. Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection.
Borges ÁH; O'Connor JL; Phillips AN; Neaton JD; Grund B; Neuhaus J; Vjecha MJ; Calmy A; Koelsch KK; Lundgren JD;
J Infect Dis; 2016 Aug; 214(3):408-16. PubMed ID: 27132283
[TBL] [Abstract][Full Text] [Related]
22. HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer.
Taylor BS; So-Armah K; Tate JP; Marconi VC; Koethe JR; Bedimo RJ; Butt AA; Gibert CL; Goetz MB; Rodriguez-Barradas MC; Womack JA; Gerschenson M; Lo Re V; Rimland D; Yin MT; Leaf D; Tracy RP; Justice AC; Freiberg MS
J Acquir Immune Defic Syndr; 2017 Aug; 75(5):500-508. PubMed ID: 28696344
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with D-dimer levels in HIV-infected individuals.
Borges AH; O'Connor JL; Phillips AN; Baker JV; Vjecha MJ; Losso MH; Klinker H; Lopardo G; Williams I; Lundgren JD; ; ;
PLoS One; 2014; 9(3):e90978. PubMed ID: 24626096
[TBL] [Abstract][Full Text] [Related]
24. Pre-therapy inflammation and coagulation activation and long-term CD4 count responses to the initiation of antiretroviral therapy.
Achhra AC; Phillips A; Emery S; MacArthur RD; Furrer H; De Wit S; Losso M; Law MG;
HIV Med; 2015 Aug; 16(7):449-54. PubMed ID: 25959989
[TBL] [Abstract][Full Text] [Related]
25. Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease.
Borges ÁH; Weitz JI; Collins G; Baker JV; Lévy Y; Davey RT; Phillips AN; Neaton JD; Lundgren JD; Deeks SG;
AIDS; 2014 Jul; 28(12):1791-6. PubMed ID: 25003720
[TBL] [Abstract][Full Text] [Related]
26. C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?
Lowe GD; Yarnell JW; Rumley A; Bainton D; Sweetnam PM
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):603-10. PubMed ID: 11304479
[TBL] [Abstract][Full Text] [Related]
27. Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?
So-Armah KA; Tate JP; Chang CH; Butt AA; Gerschenson M; Gibert CL; Leaf D; Rimland D; Rodriguez-Barradas MC; Budoff MJ; Samet JH; Kuller LH; Deeks SG; Crothers K; Tracy RP; Crane HM; Sajadi MM; Tindle HA; Justice AC; Freiberg MS;
J Acquir Immune Defic Syndr; 2016 Jun; 72(2):206-213. PubMed ID: 27824677
[TBL] [Abstract][Full Text] [Related]
28. The Effect of Rosuvastatin on Plasma/Serum Levels of High-Sensitivity C-Reactive Protein, Interleukin-6, and D-Dimer in People Living with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis.
Ashuro AA; Fan YG; Fu YS; Di DS; Sam NB; Pan HF; Ye DQ
AIDS Res Hum Retroviruses; 2021 Nov; 37(11):821-833. PubMed ID: 33913752
[TBL] [Abstract][Full Text] [Related]
29. Electrocardiographic spatial QRS-T angle and incident cardiovascular disease in HIV-infected patients (from the Strategies for the Management of Antiretroviral Therapy [SMART] study).
Dawood FZ; Khan F; Roediger MP; Zhang ZM; Swaminathan S; Klinker H; Hoy J; Lundgren JD; Neaton JD; Soliman EZ;
Am J Cardiol; 2013 Jan; 111(1):118-24. PubMed ID: 23062314
[TBL] [Abstract][Full Text] [Related]
30. Association of Lower Adiponectin Plasma Levels, Increased Age and Smoking with Subclinical Atherosclerosis in Patients with HIV-1 Infection.
Bellinati PQ; Alfieri DF; Flauzino T; Junior PFG; Rossi DJ; Breganó JW; Simão ANC; de Almeida ERD; Lozovoy MAB; Reiche EMV
Curr HIV Res; 2020; 18(4):292-306. PubMed ID: 32516102
[TBL] [Abstract][Full Text] [Related]
31. Asymptomatic myocardial ischaemia in HIV-infected adults.
Carr A; Grund B; Neuhaus J; El-Sadr WM; Grandits G; Gibert C; Prineas RJ;
AIDS; 2008 Jan; 22(2):257-67. PubMed ID: 18097228
[TBL] [Abstract][Full Text] [Related]
32. High-sensitivity C-reactive protein and interleukin-6-dominant inflammation and ischemic stroke risk: the northern Manhattan study.
Luna JM; Moon YP; Liu KM; Spitalnik S; Paik MC; Cheung K; Sacco RL; Elkind MS
Stroke; 2014 Apr; 45(4):979-87. PubMed ID: 24627113
[TBL] [Abstract][Full Text] [Related]
33. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation.
Armah KA; McGinnis K; Baker J; Gibert C; Butt AA; Bryant KJ; Goetz M; Tracy R; Oursler KK; Rimland D; Crothers K; Rodriguez-Barradas M; Crystal S; Gordon A; Kraemer K; Brown S; Gerschenson M; Leaf DA; Deeks SG; Rinaldo C; Kuller LH; Justice A; Freiberg M
Clin Infect Dis; 2012 Jul; 55(1):126-36. PubMed ID: 22534147
[TBL] [Abstract][Full Text] [Related]
34. Hepatic, Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy.
Melvin AJ; Warshaw M; Compagnucci A; Saidi Y; Harrison L; Turkova A; Tudor-Williams G;
J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e109-e115. PubMed ID: 28903520
[TBL] [Abstract][Full Text] [Related]
35. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals.
Duprez DA; Neuhaus J; Kuller LH; Tracy R; Belloso W; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Nixon D; Paton NI; Prineas RJ; Neaton JD;
PLoS One; 2012; 7(9):e44454. PubMed ID: 22970224
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression.
Hamlyn E; Fidler S; Stöhr W; Cooper DA; Tambussi G; Schechter M; Miro JM; Mcclure M; Weber J; Babiker A; Porter K;
AIDS; 2014 Mar; 28(6):869-74. PubMed ID: 24300544
[TBL] [Abstract][Full Text] [Related]
37. Circulating interleukin-6, soluble CD14, and other inflammation biomarker levels differ between obese and nonobese HIV-infected adults on antiretroviral therapy.
Koethe JR; Dee K; Bian A; Shintani A; Turner M; Bebawy S; Sterling TR; Hulgan T
AIDS Res Hum Retroviruses; 2013 Jul; 29(7):1019-25. PubMed ID: 23469772
[TBL] [Abstract][Full Text] [Related]
38. The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels.
Hamlyn E; Stöhr W; Cooper DA; Fisher M; Tambussi G; Schechter M; Miro JM; Vanobberghen F; Babiker A; Weber J; Mcclure M; Porter K; Fidler S;
AIDS; 2015 Jul; 29(11):1355-61. PubMed ID: 25870986
[TBL] [Abstract][Full Text] [Related]
39. Changes in D-dimer after initiation of antiretroviral therapy in adults living with HIV in Kenya.
Teasdale CA; Hernandez C; Zerbe A; Chege D; Hawken M; El-Sadr WM
BMC Infect Dis; 2020 Jul; 20(1):508. PubMed ID: 32664854
[TBL] [Abstract][Full Text] [Related]
40. Decreases in inflammatory and coagulation biomarkers levels in HIV-infected patients switching from enfuvirtide to raltegravir: ANRS 138 substudy.
Silva EF; Charreau I; Gourmel B; Mourah S; Kalidi I; Guillon B; De Castro N; Caron F; Braun J; Molina JM;
J Infect Dis; 2013 Sep; 208(6):892-7. PubMed ID: 23801606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
